Exploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study
Brain and Behavior · 2025
DOI: 10.1002/brb3.70745 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Xiaoli Lei und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Metabolome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Traditional Chinese Medicine Education Letter, Taishan Scholar Foundation of Shandong Province.
Abstract (Originalsprache)
Background
Evidence concerning the causal effects of blood metabolites on polycystic ovary syndrome (PCOS) risk remains scarce. A two‐sample Mendelian randomization (MR) analysis was performed among individuals of European ancestry to establish a causal relationship between plasma metabolites and the risk of PCOS.
Objective
To determine causal associations between 1400 blood metabolites and PCOS.
Methods
Utilizing data from a GWAS, which encompasses over 1400 blood metabolites, bidirectional MR was employed to explore the potential causal associations between PCOS and these metabolites. Causal inference methods included inverse variance weighting, MR‐Egger regression, weighted median, weighted mode, and simple mode approaches. Sensitivity analyses were performed to validate the robustness of the results. Reverse MR analyzed 1400 blood metabolites as outcomes and PCOS as the exposure.
Results
Fifteen plasma metabolites, including methionine sulfoxide, N‐acetylserine, and glycine, exhibited positive causal effects on PCOS risk. In contrast, 13 metabolites, including threonate, 7‐methylguanine, and theophylline, demonstrated protective effects. Leave‐one‐out analysis confirmed the stability of the results, with no influential instrumental variables, and eliminated the impacts of heterogeneity and horizontal pleiotropy. Reverse MR revealed no evidence of causal associations between PCOS and the metabolites.
Conclusion
Thirteen plasma metabolites were identified as protective factors for PCOS. Targeted modulation of these metabolites may improve metabolic dysfunction in patients, alleviating symptoms and enhancing quality of life. Further exploration of metabolite dynamics could advance mechanistic insights into PCOS pathogenesis and inform therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Reproductive Genetics, Taian Central Hospital, Taian, China.
- Department of Endocrinology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
ORCID-Profile: Xiaoli Lei, Xiaobei Liu, Yi Qu, Yanqin Huang
Förderung
- National Traditional Chinese Medicine Education Letter
- Taishan Scholar Foundation of Shandong Province
Zitieren
APA
Lei, X., Liu, X., Qu, Y., & Huang, Y. (2025). Exploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study. Brain and Behavior. https://doi.org/10.1002/brb3.70745
Vancouver
Lei X, Liu X, Qu Y, Huang Y. Exploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study. Brain and Behavior. 2025. doi:10.1002/brb3.70745
BibTeX
@article{Lei2025,
author = {Lei, Xiaoli and Liu, Xiaobei and Qu, Yi and Huang, Yanqin},
title = {Exploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70745}
}
EUVIMED